The aim of the study was to investigate whether routine clinical parameters, including visceral adiposity index (VAI) and atherogenic index of plasma (AIP), could become widely applicable predictors of insulin resistance (IR), evaluated using homeostasis model assessment (HOMA-IR, HOMA-β), with regard to presence of metabolic syndrome (MS).
Introduction
Globally, chronic noninfectious diseases play an important role and increasingly contribute to overall mortality. There is therefore a growing need to search for and use new preventive methods. Metabolic syndrome (MS), grouping factors crucial for the development of diseases of affluence, has been defined as a single nosological entity, among others, to clearly identify individuals with high cardiovascular risk eligible for targeted preventive interventions (Paniagua 2016) .
Obesity is a major clinical problem in developed societies. It is well known that obesity and MS are associated with increased morbidity and mortality (Matloch et al. 2016) .
According to some definitions, visceral obesity, as measured by waist circumference (WC), is stressed over other components of MS (Kassi et al. 2011) . In the state of obesity, subjects already present insulin resistance (IR) and hyperinsulinemia, probably the first step of a dysfunctional metabolic system. Subsequently, other disorders develop gradually, in particular hyperglycemia, dyslipidemia and hypertension, that is, those targeted by routine screening in primary care (Paniagua 2016) . It means that IR usually starts as early as at the time when parameters of routine screening still may not show abnormal values. Effective detection of early IR could therefore contribute to identification of potential at-risk individuals. Similarly, effective and available objective assessment of IR in already identified at-risk individuals with MS could aid in predicting complication such as type 2 diabetes mellitus (T2DM).
A method for detecting IR that is easy to use in common clinical practice albeit still rather expensive for widespread use is homeostasis model assessment (HOMA). Its satisfactory correlation with the most accurate glucose clamp techniques has been confirmed by numerous studies. These simple mathematical models based on the knowledge of a single fasting glucose and insulin value reflect the level of resistance of peripheral tissues to insulin (HOMA-IR) or pancreatic beta cell function (HOMA-β) (Wallace et al. 2004) .
Recently, there has been an increase in information in the literature about a relatively new predictive model called visceral adiposity index (VAI) that seems to be a reliable indicator of visceral adipose dysfunction; its increase is strongly associated with cardiometabolic risk (Amato et al. 2010) . Similarly, atherogenic index of plasma (AIP) is associated with cardiometabolic risk. AIP reflects the true relationship between protective and atherogenic lipoprotein and is associated with the size of pre-and anti-atherogenic lipoprotein particles (Li et al. 2018) . Unlike HOMA, both VAI and AIP may be calculated without knowing the patient's insulin concentration and only routine parameters are needed (serum lipids for AIP, plus basic anthropometric data for VAI).
The study aimed to assess the relationship between routinely used parameters and indirect IR markers, namely HOMA, with respect to the presence of MS, and to explore whether, and if so to what extent, VAI and AIP are associated with IR in those patients.
Methods

Study subjects
The study comprised two groups differing in the presence of MS. Those included in the MS group met the International Diabetes Federation (IDF) criteria for diagnosing MS (Alberti et al. 2005) , one of the widespread and commonly used definition of MS. Between March 2017 and September 2018, such individuals eligible for the study were selected in two general practitioners' offices in the Pardubice Region, Czech Republic. The MS group comprised 188 individuals (73 males and 115 females) with a mean age of 56 years. In these subjects, the below laboratory analysis were performed and, at the same time, their basic anthropometric parameters (height, weight, WC) and blood pressure (BP), as a mean of three resting recordings at a single visit, were measured. The obtained data were used to calculate Body Mass Index (BMI), HOMA-IR, HOMA-β, VAI and AIP for each participant. An equal number of controls without meeting the IDF criteria of MS was age-and sex-matched as par with the MS group. Those included in the control group were selected from the database of patients' first visits in an Outpatient center of the 3 rd Department of Internal Medicine, University Hospital Olomouc. None of the subjects of both groups was treated with oral antidiabetic drugs or insulin.
The study was conducted according to the principles stated in the Declaration of Helsinki. For being included in the study, all subjects signed informed consent forms after they were explained all information regarding the study.
Laboratory analysis
All laboratories participating in the study meet the same national accreditation. In all cases, the principles of proper laboratory practice were followed and the laboratories were under systematic intra-and inter-laboratory control of the accuracy of examinations.
In the MS group, venous blood was always sampled in the morning, after 12-hour fasting, in a single collection point of an accredited laboratory (MeDiLa Ltd., Pardubice).
There, under standard conditions, the following biochemistry parameters were analyzed: glucose, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides, uric acid (UA), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). The above parameters were measured on the Architect c16000 analyzer (Abbott Laboratories, Illinois, USA) using fresh serum on the day of blood sampling. To determine serum insulin concentrations, serum was deep frozen within no more than 2 hours from blood sampling. The separated serum was stored at -80°C until assay. The insulin concentration analysis itself was carried out at the Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové on the Architect i1000SR analyzer (Abbott Laboratories) using chemiluminescent microparticle immunoassay.
In the control group, the same routine serum parameters were analyzed on the Cobas 8000 analyzer (Roche, Mannheim, Germany) on the day of blood sampling at the Department of Clinical Biochemistry, University Hospital Olomouc. Serum insulin concentrations were determined by the commercially available kits (Immunotech, Marseille, France) using specific antibodies by IRMA methods.
Statistical analysis
Statistical analyses were conducted with the R software environment (R Foundation for Statistical Computing, Austria; http://www.r-project.org/). All numerical variables were characterized with descriptive statistics. Correlations of selected variables were quantified with Pearson's correlation coefficient (r) and the level of significance (p) was determined.
Multivariate linear regression was performed to examine the relationships between the parameters, including VAI and AIP, as regressors of the dependent variables HOMA-IR and HOMA-β. The results of regression analysis are presented in the form of linear coefficients (β). P value of less than 0.05 indicates statistical significance. Extreme values of glucose and insulin were found and excluded using the inner and outer fences method. All variables of our interest followed normal or near-normal distribution. The following formulas were used to calculate the aforementioned indices (Wallace et al. 2004 , Dobiasova and Frochlich 2001 , Amato et al. 2010 :
Results
Characteristics of the study population
Basic metabolic and clinical characteristics are expressed as the mean of all values with the lower and upper limits of the 95% confidence interval (Table 1 ). It is apparent that most MS parameters were borderline or abnormal in the MS group. The mean values of WC (112.9 cm in males, 105.7 cm in females) were within the obesity range (according the IDF criteria) for both sexes. Those were individuals with visceral obesity only. As for other MS diagnostic criteria, glucose levels ≥ 5.6 mmol/l were commonly observed, namely in 56.2% of males and 49.6% of females. Glucose levels ≥ 7 mmol/l were present in 9.6% of males and 8.7% of females, respectively. As seen from Table 1 , the mean systolic BP was slightly above the threshold for the applied MS criteria whereas the mean diastolic BP was below the threshold. Among the means of lipid parameters contained in the definition of MS, only triglycerides in males (1.81. mmol/l) were abnormal. It must be noted, however, that longterm antihypertensive and hypolipidemic therapy (both statins and fibrates) was widely used in the MS group. In the control group, means of all MS parameters were normal with the only exception of the borderline mean value of WC in females (80.2 cm). All tested parameters differed significantly between the groups except for TC and LDL-C.
Correlation analysis
In the MS group, the highest correlation coefficients were noted between WC and IR markers, namely correlations of WC with HOMA-IR (r = 0.57), HOMA-β (r = 0.39) and
insulin concentration alone (r = 0.56), as seen from Table 2 and Fig. 1 . However, WC was only weakly correlated with glucose alone (r = 0.19). Similar correlations were found for BMI, with correlation coefficients being generally lower than in case of WC. Both HOMA and insulin were also moderately correlated with liver transaminases, the strongest being correlations of ALT with insulin concentration (r = 0.44) and HOMA-IR (r = 0.41).
Statistically significant were also correlations of systolic and diastolic BP with HOMA-IR (r = 0.37 and r = 0.34, respectively), insulin concentration alone (r = 0.32 and r = 0.31, respectively) and glucose (r = 0.33 and r = 0.22, respectively). As for the parameters not directly associated with IR, there were statistically highly significant (p < 0.001) correlations of WC and BMI with both systolic (r = 0.42 and r = 0.31, respectively) and diastolic BP (r = 0.45 and r = 0.36, respectively) and HDL-C (r = -0.34 and r = -0.32, respectively). As expected, correlations of VAI and AIP with parameters included in their calculations were strong and statistically significant. As for the parameters not included in the calculations of VAI and AIP, the strongest correlations were found in BP and UA, specifically the strongest between AIP and UA (r = 0.41).
In the control group, an association of the anthropometric indices with HOMA was generally weaker than in the MS group, without an apparent difference between WC and BMI (Table 2 ). There were moderate correlations of both insulin and HOMA-IR with ALT and AST, respectively, with the highest correlation coefficient noted between HOMA-IR and ALT (r = 0.57) (Fig. 2) . Also notable was an association of UA with both insulin (r = 0.46) and
HOMA-IR (r = 0.44). Correlation coefficients of HOMA-β were generally very low (Table 2) .
Regression analysis
The impact of individual HOMA predictors is expressed with multivariate linear regression models that use linear coefficients (β) to show the effects of 1-point increases of these predictors on HOMA (Table 3) . As for HOMA-IR, there were statistically significant results for its relationships with WC, ALT and systolic BP. For HOMA-β, the statistically significant predictors were WC and ALT; unlike HOMA-IR, the result for an inverse association between HOMA-β and age was statistically significant. The presence of MS was a significant predictor of both HOMA-IR and HOMA-β. For example, if WC increases by 1 point, HOMA-IR and HOMA-β will increase by a mean of 0.1 (p < 0.001) and 1.97 (p = 0.032), respectively. If ALT increases by 1 point, the increases of HOMA-IR and HOMA-β will increase by 2.28 (p < 0.001) and 99.49 (p = 0.004), respectively. With each year of age HOMA-β will decrease by a mean of 1.31 (p = 0.004).
Discussion
The obtained results of both correlation and regression analyses demonstrate strong relationships between WC and IR markers in individuals with MS. However, the same regression analysis results were not observed for BMI. The ability of WC to predict IR may be beneficial, mainly from a primary health care practitioner's perspective, given the ease with which WC is measured. Our results are similar to those of a cross-sectional study by It is known that AIP is associated with obesity and increased cardiovascular risk.
Pearson's correlation analysis of 5351 middle-aged males from Southeastern China revealed that AIP was positively correlated with WC (r = 0.37, p < 0.001) (Shen et al. 2018) . In their study, Li et al. divided 2523 individuals with T2DM who had not been treated with lipidlowering drugs into tertiles based on their AIP values. There was a significant increase in HOMA-IR between the tertiles. Multiple logistic regression analysis showed that WC, HOMA-IR, fasting glucose, systolic BP and UA were independent risk factors for AIP (Li et al. 2018) . The present study documented several rather weak statistically highly significant correlations of AIP (Table 2) , however, regression analysis did not confirm the ability of AIP to predict HOMA.
A cross-sectional study including 1834 Chinese adults with normal WC assessed the correlation between VAI and HOMA-IR. VAI gradually increased across HOMA-IR quartiles and correlation analysis showed that VAI was positively related to HOMA-IR. Logistic regression analysis indicated that VAI elevation was the main risk factor for the increased HOMA-IR in both genders (Ji et al. 2017 ). In the present study, regression analysis failed to confirm a significant association between HOMA-IR and VAI and only showed statistically significant correlations of VAI with LDL-C, UA and BP in the MS group (Table 2) .
The study has certain limitations. One is the fact that it used laboratory data obtained by single measurement, causing possible bias due to natural intra-individual variability of the analyzed parameters, as is well known, for instance, in fasting glucose (Pasqualetti et al. 2017 ). Another limitation is that common long-term antihypertensive and hypolipidemic therapy was widespread in the study population (especially in the MS group), affecting plasma lipid levels and BP values.
In conclusion, correlation and regression analysis confirmed significant associations between HOMA and some routinely examined parameters. In addition to systolic BP, significant predictors for HOMA-IR were also ALT and WC, clearly the most significant predictor. The association of WC with HOMA-IR increases with a number of metabolic 
